ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,179.27
0.46%
Dow Jones
38,778.10
0.49%
Gold vs US Dollar
2,318.345
-0.09%
Brent Oil
83.625
-0.33%
Bitcoin
65,748.85
-1.11%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Rhythm Pharmaceuticals Inc (RYTM)

  7. Rhythm Pharmaceuticals Inc (RYTM) News

Rhythm Pharmaceuticals (RYTM)

Rhythm Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RYTM
DateTimeSourceHeadlineSymbolCompany
17/06/202422:28Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:RYTMRhythm Pharmaceuticals Inc
17/06/202422:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYTMRhythm Pharmaceuticals Inc
11/06/202421:01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces New Employment Inducement GrantsNASDAQ:RYTMRhythm Pharmaceuticals Inc
03/06/202421:02GlobeNewswire Inc.Rhythm Pharmaceuticals Presents Patient-reported Experiences with Hyperphagia in Hypothalamic Obesity at ENDO 2024NASDAQ:RYTMRhythm Pharmaceuticals Inc
03/06/202413:02GlobeNewswire Inc.Rhythm Pharmaceuticals Announces Participation at Upcoming Investor ConferenceNASDAQ:RYTMRhythm Pharmaceuticals Inc
22/05/202409:00GlobeNewswire Inc.Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl SyndromeNASDAQ:RYTMRhythm Pharmaceuticals Inc
13/05/202421:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
09/05/202421:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
09/05/202421:01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces New Employment Inducement GrantsNASDAQ:RYTMRhythm Pharmaceuticals Inc
07/05/202421:43Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RYTMRhythm Pharmaceuticals Inc
07/05/202412:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYTMRhythm Pharmaceuticals Inc
07/05/202412:00GlobeNewswire Inc.Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business UpdateNASDAQ:RYTMRhythm Pharmaceuticals Inc
06/05/202413:00GlobeNewswire Inc.Rhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual MeetingNASDAQ:RYTMRhythm Pharmaceuticals Inc
29/04/202423:30GlobeNewswire Inc.Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & EndocrinologyNASDAQ:RYTMRhythm Pharmaceuticals Inc
24/04/202421:01GlobeNewswire Inc.Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024NASDAQ:RYTMRhythm Pharmaceuticals Inc
16/04/202421:01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces New Employment Inducement GrantsNASDAQ:RYTMRhythm Pharmaceuticals Inc
01/04/202413:00GlobeNewswire Inc.Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock FinancingNASDAQ:RYTMRhythm Pharmaceuticals Inc
25/03/202412:00GlobeNewswire Inc.Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific AgonistNASDAQ:RYTMRhythm Pharmaceuticals Inc
11/03/202420:01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces New Employment Inducement GrantsNASDAQ:RYTMRhythm Pharmaceuticals Inc
06/03/202421:01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces Participation at Upcoming Investor ConferencesNASDAQ:RYTMRhythm Pharmaceuticals Inc
29/02/202421:58Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:RYTMRhythm Pharmaceuticals Inc
29/02/202421:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYTMRhythm Pharmaceuticals Inc
29/02/202421:44Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RYTMRhythm Pharmaceuticals Inc
29/02/202421:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RYTMRhythm Pharmaceuticals Inc
22/02/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYTMRhythm Pharmaceuticals Inc
22/02/202412:01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in JapanNASDAQ:RYTMRhythm Pharmaceuticals Inc
22/02/202412:00GlobeNewswire Inc.Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business UpdateNASDAQ:RYTMRhythm Pharmaceuticals Inc
22/02/202400:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
22/02/202400:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
22/02/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RYTM

Your Recent History

LSE
SCE
Surface Transforms
LSE
QBT
Quantum Blockchain Techn...
LSE
BIRD
Blackbird
LSE
GKP
Gulf Keystone Petroleum
LSE
TERN
Tern
LSE
AAZ
Anglo Asian Mining
LSE
OXB
Oxford Biomedica
LSE
CPX
Cap-xx
LSE
VAST
Vast Resources
LSE
HE1
Helium One Global
LSE
POS
Plexus
LSE
SBTX
Skinbiotherapeutics
LSE
AFC
Afc Energy
LSE
CHLL
Chill Brands
LSE
ALTN
Altyngold
LSE
RESI
Residential Secure Income
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved